These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6253000)

  • 21. Growth kinetics of human large bowel cancer growing in immune-deprived mice and some chemotherapeutic observations.
    Lamerton LF; Steel GG
    Cancer; 1975 Dec; 36(6 Suppl):2431-6. PubMed ID: 1212661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological and pharmacological characterisation of three models of human ovarian carcinoma established in nude mice: use of the CA125 tumour marker to predict antitumour activity.
    Burbridge MF; Kraus-Berthier L; Naze M; Pierre A; Atassi G; Guilbaud N
    Int J Oncol; 1999 Dec; 15(6):1155-62. PubMed ID: 10568822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the chemosensitivity of a primary tumour and its metastases using a human tumour xenograft.
    Selby PJ; Thomas JM; Peckham MJ
    Eur J Cancer (1965); 1979 Dec; 15(12):1425-9. PubMed ID: 535604
    [No Abstract]   [Full Text] [Related]  

  • 24. Hexamethylmelamine-induced regression of human lung tumors growing in immune deprived mice.
    Mitchley BC; Clarke SA; Connors TA; Neville AM
    Cancer Res; 1975 Apr; 35(4):1099-102. PubMed ID: 1116144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of xenografts for the evaluation of tumor chemotherapy. Application to adjuvant chemotherapy].
    Duplan JF
    Bull Cancer; 1984; 71(4):292-6. PubMed ID: 6498344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A lung colony clonogenic cell assay for human malignant melanoma in immune-suppressed mice and its use to determine chemosensitivity, radiosensitivity and the relationship between tumour size and response to therapy.
    Thomas JM
    Br J Surg; 1979 Oct; 66(10):696-700. PubMed ID: 509043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of a new nitrosourea (TCNU) in human lung cancer xenografts.
    Fergusson RJ; Anderson LE; Macpherson JS; Robins P; Smyth JF
    Br J Cancer; 1988 Apr; 57(4):339-42. PubMed ID: 3390369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts.
    Berman R; Steel GG
    Br J Cancer; 1984 Apr; 49(4):431-6. PubMed ID: 6324838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice.
    Papadopoulou MV; Ji M; Ji X; Bloomer WD; Hollingshead MG
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):501-8. PubMed ID: 12451478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The therapeutic response of three human tumor lines maintained in immune-suppressed mice.
    Kopper L; Steel GG
    Cancer Res; 1975 Oct; 35(10):2704-13. PubMed ID: 1157045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor marker production in human bronchial carcinoma xenografts.
    Shorthouse AJ; Carter SM; Ellison ML
    Oncodev Biol Med; 1982; 3(4):273-81. PubMed ID: 6291006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity of anticancer agents, growth and chemosensitivity of human tumour xenografts in a segregating stock of AF nude mice.
    Maruo K; Emura R; Ohnishi Y; Endo S; Ueyama Y; Nomura T
    Lab Anim; 1991 Oct; 25(4):342-7. PubMed ID: 1753695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of tumour growth and of response to chemotherapy of human melanomas in athymic, nude mice.
    Fodstad O; Aass N; Pihl A
    Br J Cancer Suppl; 1980 Apr; 4():146-9. PubMed ID: 6932918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker.
    Heath-Engel HM; Lingwood CA
    Angiogenesis; 2003; 6(2):129-41. PubMed ID: 14739619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.
    Warenius HM; Freedman LS; Bleehen NM
    Br J Cancer Suppl; 1980 Apr; 4():128-32. PubMed ID: 6932916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy of human tumors in T-lymphocyte-deficient mice.
    Mitchley BC; Clarke SA; Connors TA; Carter SM; Neville AM
    Cancer Treat Rep; 1977; 61(3):451-62. PubMed ID: 406045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.